Table of contents
About the talk
For some time, terpenes were considered waste molecules leftover after extracting CBD. Those times were short-lived, however, since there is an abundant wealth of scientific literature demonstrating the medicinal merit of terpenes like beta-caryophyllene, linalool, bisabolol, nerolidol, and more. For example, nerolidol and linalool are useful in treating anxiety, whereas beta-caryophyllene is useful in relieving pain. While some patients may benefit from more one-dimensional CBD products like isolate, the terpenes native to the plant can help augment the benefits of the extracted cannabinoid(s). They provide the exquisite bouquets that emanate from the plants, and drive the organoleptic properties that patients experience. This panel will discuss the importance of terpenes, and how adding these precious little molecules back in to CBD oils can differentiate a product to have a defined medical purpose.
03:50 What are terpenes?
05:43 Typical terpene concentration
07:59 Are terpenes medically active?
12:00 Terpenes in cannabinoid-infused products and their effect
14:25 Terpenes in precision and personalized medicine
15:48 Terpene concentration in products
19:20 Safety concerns of combusting terpenes
23:56 Terpenes on product labels
Managing scientific and research operations; setting relevant and science based priorities within the organization; aligning priorities with those of the organization's overall mission; overseeing research projects; developing new processes/technologies; combining knowledge with leadership skills; promoting efficiency and profitability of the company; staying up-to-date on industry trends; advising and training the organization regarding scientific matters; identifying new research opportunities; coordinating research activities; recruiting scientists and researchers; managing and evaluating personnel; serving various public relations roles; and traveling to meet with executives within the organization.View the profile
Stephen Goldman is an analytical chemist with extensive industrial and academic laboratory experience. He brings to PhytaTechSM expertise in GC, HPLC and mass spectrometry, chemical and biochemical engineering as well as project and business management. Prior to joining PhytaTechSM, Stephen served as an analytical chemist at the CLIA and CAP certified Forensic Laboratories, overseeing toxicology testing. Earlier, he was a scientist-chemist for Novartis (Sandoz), Kemin Industries, Genentech and served as a contract chemist. In that capacity, Stephen was involved in research into biocatalyst production and new chemistry products, neutraceuticals, antibody conjugate linkers, technical services, quality control, analytical method development and validation. Before embarking on a career in the private sector, he was a research assistant in academic laboratories at the University of Kansas and the University of Iowa. There, he engaged in research into the intracellular trafficking, cellular localization and stability of small molecules as well as the purification and quantification of heparin oligosaccharides. Stephen has published a number of research papers in the fields of biological and analytical chemistry. He is a member of the American Institute of Chemical Engineers, American Association of Pharmaceutical Scientists and the American Chemical Society.View the profile
Jake is a co-founder at Treehouse and serves as the Chief Scientific Officer. As CSO he leads a team of chemists working to lead the industry in cannabinoid isolation and formulation. Jake obtained his PhD in Organic Chemistry from Yale University as an NSF Graduate Research Fellow, and his B.S. in Chemistry with Honors from Villanova University. Jake’s research focused on medicinal chemistry and the development of new spectroscopic methods, fields in which he has authored multiple papers.View the profile
In general, my career has specialized in biotechnology, genomics and some computational biology. In graduate school and postdoc I researched the molecular evolution of natural products utilizing Terpenes (Terpenoids) as a model for study. My graduate work was focused on studying the horizontal gene transfer of the biosynthetic pathway of a terpene called trichothecenes, a toxic compound produced by a fungus that cause contamination to wheat crops. My postdoc research investigated the first gene in the pathway of many terpenes the terpene synthase and performed a comparative study of terpene synthases across a number of plants that sequence information was available for during that time. Susan is interested in utilizing her background in terpene and genomics to lead the way for precision medicine (sometimes called personalized medicine) in the cannabis industry. Aka utilizing genomics to predict how individuals will respond to various cannabinoids and terpene treatments and combinations.View the profile
Registered Nurse, Certified Aromatherapist, Entrepreneur and Cannabis Wellness Educator. Wendy is the Founder and creator of Clean Coconut Skincare & Wellness. Like many in the cannabis industry, Wendy’s journey has been a personal one. She set out to create natural pain relief and skin care products to relieve common pain and skin ailments.View the profile
Hello, everyone. Today we're going to be talking about terpenes and how they interact with cannabis therapies. I will start off with introductions. I'll start with myself and then pass it on to the rest of the panelists on my name is Tamar Wise. I'm the Owner of Wise Science Consulting a Botanical science consulting firm. I've been in the industry for about 11 years and I specialize in product formulation and development as well as infusions and then I will pass this on to Wendy. Hi, everyone, Wendy
Pagadian. I'm a registered nurse certified aromatherapist cannabis educator and owner of a topical company called Clean Coconut and we'll just start with us some basic interests and then we'll move on to our first topic. Greetings everyone. Can you hear me? My name is Susan Trapp and I'm part of a couple of startups. So one called EndoSyn, which is trying to harness your own internal and cannabinoids. Another company is called Terpedia. We're trying to collate information
on terpenes and thirdly another company called Trials Grab that's a platform for acted aggregation and analytics in the Cannabis industry. I have a background. I actually studied terpenes way before they were of interest in the Cannabis industry for my Ph.D. in my postdoc having nothing to
Buy this talk
Access to all the recordings of the event
Interested in topic “Cannabis & CBD”?
You might be interested in videos from this event
Buy this video
Our other topics
With ConferenceCast.tv, you get access to our library of the world's best conference talks.